| Literature DB >> 30622419 |
Rakesh Varghese1, Mohammed A Almalki2, Soundharrajan Ilavenil3, Jeyanthi Rebecca1, Ki Choon Choi3.
Abstract
BACKGROUND: Synthesis of silver nanoparticles (AgNPs) through biological route plays an important role in their applications in the medical field, especially in the prevention of disease causing microbial pathogens and arresting the propagation of cancer cells. The stable, green synthesis of AgNPs is very much welcomed in the medical field because of their low toxicity. Therefore, the demands of AgNPs synthesised biologically is on the rise. The present study aimed to investigate the antimicrobial mechanisms and anticancer properties of the AgNPs synthesized using the seed extract of Trigonella foenum-graecum L. The AgNPs were characterized by UV-vis, SEM, XRD, FTIR and EDAX analysis. The minimum inhibitory concentrations (MIC) of the AgNPs were determined by the broth micro dilution method.Entities:
Keywords: AgNPs; Anticancer activity; Antimicrobial activity; Antimicrobial mechanism; FTIR; Trigonella foenum-graecum L.
Year: 2017 PMID: 30622419 PMCID: PMC6319018 DOI: 10.1016/j.sjbs.2017.07.001
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
Fig. 1Ultraviolet–visible absorption spectra of the AgNPs synthesized using the seed extract of Trigonella foenum-graecum L.
Fig. 2XRD spectra of the AgNPs synthesized using the seed extract of Trigonella foenum-graecum L.
Fig. 3FTIR spectra of the AgNPs synthesized using the seed extract of Trigonella foenum-graecum L.
Fig. 4Particle size the AgNPs synthesized using the seed extract of Trigonella foenum-graecum L.
Minimum inhibitory concentration of the AgNPs against bacteria and fungi.
| Microorganisms | Minimum inhibitory concentration | ||
|---|---|---|---|
| Nanoparticles (µg/mL) | Water extract (mg/mL) | Standard µg/mL) | |
| 125 | 6.25 | 25 | |
| 250 | 1.25 | 25 | |
| 62.5 | 6.25 | 37.5 | |
| 500 | 6.25 | 50 | |
| 500 | 5 | 50 | |
| 250 | 2.5 | 25 | |
| 500 | 2.5 | 100 | |
| 250 | 2.5 | 50 | |
| 500 | 2.5 | 25 | |
| 250 | 5 | 50 | |
Standard: Streptomycin and Ketoconazole.
Fig. 5Antimicrobial activity of the AgNPs synthesized using the seed extract of Trigonella foenum-graecum L. against bacterial pathogens. A: Klebsiella pneumoniae; B: Staphylococcus aureus; C: Salmonella typhi.
Fig. 6Antimicrobial mechanism of the AgNPs synthesized using the seed extract of Trigonella foenum-graecum L. against bacterial pathogens. A: Extra cellular protein level; B: Lactate dehydrogenase assay; C: Alkaline phosphatase assay.
Fig. 7Anticancer activity of the AgNPs synthesized using the seed extract of Trigonella foenum-graecum L. against MCF7 and VERO cell lines. A1: MCF7 cell line control; A2: MCF7 at 1.56 µg; A3: MCF7 at 3.12 µg; B1: VERO cell line control; B2: MCF7 at 1.56 µg; B3: MCF7 at 3.12 µg.